Drug intelligence / Profile preview

conventional therapy + hUC-MSCs

Development stage: Unknown
Lead developer: Beike Biotechnology
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

This investigational combination therapy pairs standard conventional medical treatment with human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) developed by Shenzhen Beike Bio-Technology Co., Ltd. The hUC-MSCs are multipotent stromal cells harvested from Wharton's jelly of the umbilical cord, known for their immunomodulatory, anti-inflammatory, and regenerative properties. In the context of decompensated liver cirrhosis, these cells are intended to migrate to the injured liver tissue and exert paracrine effects that reduce fibrosis, promote hepatocyte regeneration, and modulate the systemic inflammatory response characteristic of end-stage liver disease. The therapy has been evaluated in Phase I/II clinical trials to assess safety and efficacy in improving liver function markers such as albumin levels and coagulation parameters.

Other names: human umbilical cord mesenchymal stem cellshUC-MSCs (Shenzhen Beike)hUC-MSCs transplantation

Beyond the preview

Go deeper on conventional therapy + hUC-MSCs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on conventional therapy + hUC-MSCs.

Explore the full profile